Daiichi Sankyo, Ranbaxy deal

Daiichi increased its stake in Ranbaxy from 52.5% to 63.9% by completing the previously announced acquisition of 130 million shares held by Ranbaxy CEO and Managing Director Malvinder Mohan Singh at R...